Skip to content
logo transparent png
  • Home
  • About
    • About
    • Meet the Team
      • Scott Brinks, Owner and Chief Consultant
      • Sarah Boblenz , Senior Consultant
  • Blog & News
  • Services
    • Affordable Pricing
    • Customer Service
    • DEA Compliance Training
    • DEA Outreach
    • Enterprise Solutions
    • Interpreting Complex DEA Rules
    • Litigation & DEA Expert Witness Services
    • Inspections and Audits
    • Policy Review
    • Rapid DEA Compliance Response
    • DEA Regulatory Interpretation
    • Standard Operating Procedures
  • How to?
    • How To Register/Renew a DEA Registration
    • How to Verify a DEA Number
  • Content
Search
Newsletter
Newsletter
logo transparent png
  • Home
  • About
    • About
    • Meet the Team
      • Scott Brinks, Owner and Chief Consultant
      • Sarah Boblenz , Senior Consultant
  • Blog & News
  • Services
    • Affordable Pricing
    • Customer Service
    • DEA Compliance Training
    • DEA Outreach
    • Enterprise Solutions
    • Interpreting Complex DEA Rules
    • Litigation & DEA Expert Witness Services
    • Inspections and Audits
    • Policy Review
    • Rapid DEA Compliance Response
    • DEA Regulatory Interpretation
    • Standard Operating Procedures
  • How to?
    • How To Register/Renew a DEA Registration
    • How to Verify a DEA Number
  • Content
Newsletter Signup
Newsletter Signup

Brinks DEA Consulting Content Posts

Content
  • Choosing A DEA Consultant
  • Actions
  • Definitions
  • DEA Forms
    • DEA Form 41
    • DEA Form 106
    • DEA Form 222
  • Long Term Care Pharmacy
  • Marijuana Rescheduling
  • Pharmacy
  • Security
  • Choosing A DEA Consultant
  • Actions
  • Definitions
  • DEA Forms
    • DEA Form 41
    • DEA Form 106
    • DEA Form 222
  • Long Term Care Pharmacy
  • Marijuana Rescheduling
  • Pharmacy
  • Security
Downloadable Documents
  • Document Library
  • Document Library
Link Library
Link Library

Will Ibogaine Be the New Trend in Psychedelic Therapy?

Will the U.S. Expand Methadone Prescribing for Opioid Addiction?

Is the DEA’s non-retrievable standard too much? Maybe it’s time to change the non-retrievable standard?

Important Question: What will DEA List on the Unified Agenda Spring 2026?

Why Congress Must Fix 21 U.S.C. 829a(a): The Hidden Impact of the SUPPORT Act on Patient Care. Do you know the serious issues this law created—and how they could be limiting access to treatment?

Navigating CMS Hospital-at-Home Rules and the Controlled Substances Act: Compliance Strategies You Can Implement Today

Do You Know The History of Controlled Substance Schedules and Drug Control?

Critical Question: Are You Meeting DEA Security Requirements for Controlled Substances Compliance?

Understanding DEA Compliance in Guidance Updates

A Word On Public Service 

DISCLAIMER

We offer expert guidance on controlled substance compliance and regulatory strategy, informed by prior DEA experience but unaffiliated with the agency. We do not provide legal services; for legal advice, please consult a licensed attorney.

Get In Touch

Brinks DEA Consulting
PO Box 185
Mathias, WV 26812
216-313-8191

Copyright © 2026 Brinks DEA Consulting and Compliance | Powered by Brinks DEA Consulting and Compliance